dockets: FTC-2023-0061

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id title docket_type last_modified object_id rin dkabstract category subtype keywords program short_title effective_date organization attrs_raw attr_source
FTC-2023-0061 FTC FTC Seek Comments on HISA Anti-Doping and Medication Control Rule Modification, Matter No. P222100 Nonrulemaking 2025-05-28T12:15:37Z 0b00006485ff02aa   As required by the Horseracing Integrity and Safety Act of 2020, the Federal Trade Commission (‘‘FTC’’ or ‘‘Commission’’) publishes a proposed rule modification related to the equine Anti-Doping and Medication Control Program of the Horseracing Integrity and Safety Authority (‘‘HISA’’ or the ‘‘Authority’’). Specifically, the proposed rule modification would designate iron dextran as a banned substance and thereby prohibit its use. This publication contains the Authority’s proposed rule’s text and explanation, and it seeks public comment on whether the Commission should approve the proposed rule.               {"displayProperties": [{"name": "abstract", "label": "Description", "tooltip": "Describes an agency's specific regulatory action; equivalents: Abstract, Docket Subject, General Info, Related To, Summary."}], "keywords": null, "modifyDate": "2025-05-28T12:15:37Z", "dkAbstract": "As required by the Horseracing Integrity and Safety Act of 2020, the Federal Trade Commission (\u2018\u2018FTC\u2019\u2019 or \u2018\u2018Commission\u2019\u2019) publishes a proposed rule modification related to the equine Anti-Doping and Medication Control Program of the Horseracing Integrity and Safety Authority (\u2018\u2018HISA\u2019\u2019 or the \u2018\u2018Authority\u2019\u2019). Specifically, the proposed rule modification would designate iron dextran as a banned substance and thereby prohibit its use. This publication contains the Authority\u2019s proposed rule\u2019s text and explanation, and it seeks public comment on whether the Commission should approve the proposed rule.", "agencyId": "FTC", "program": null, "shortTitle": null, "subType2": null, "title": "FTC Seek Comments on HISA Anti-Doping and Medication Control Rule Modification, Matter No. P222100", "generic": null, "field1": null, "docketType": "Nonrulemaking", "petitionNbr": null, "rin": null, "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006485ff02aa"} single_get

Links from other tables